YTHDF1 and ovarian carcinoma: Up-regulation of YTHDF1 is associated with the poor prognosis of ovarian cancer patients and knockdown of YTHDF1 can inhibit the stem cell-like features of cisplatin-resistant ovarian cancer cells.